Furthermore, the data revealed a potential molecular mechanism by which Cx32, in a GJ-independent manner, exerts anti-apoptotic effects to protect HCC cells from chemotherapeutic exposure by interacting with Src kinase and activating the EGFR signaling pathway in vitro and in vivo. Here, EGFR is linked to hepatocellular carcinoma.